HOME >> MEDICINE >> NEWS
UK study quantifies cancer risk from diagnostic X-rays

The most detailed calculation of its kind to estimate the risk of cancer from exposure to diagnostic X-rays is published in this week's issue of THE LANCET. It suggests that in the UK around 700 of the 124,000 cases of cancer diagnosed annually could be attributable to exposure to diagnostic X-rays.

Diagnostic X-rays (used in conventional radiography and imaging techniques such as computed tomography [CT]) are the largest man-made source of radiation exposure to the general population, contributing about 14% of the total annual exposure worldwide from all sources. Although diagnostic X-rays provide great benefits, it is generally accepted that their use is associated with very small increases in cancer risk.

Amy Berrington de Gonzlez (University of Oxford, UK) and Sarah Darby (Cancer Research UK) have estimated the likely extent of the cancer risk based on the annual number of diagnostic X-rays undertaken in the UK and in 14 other developed countries (Australia, Canada, Croatia, Czech Republic, Finland, Germany, Japan, Kuwait, the Netherlands, Norway, Poland, Sweden, Switzerland, and the USA).

The investigators estimate that in the UK about 0.6% of the cumulative risk of cancer to age 75 years may be attributable to diagnostic X-rays - equivalent to around 700 cancer cases annually. The proportions of cases attributable to diagnostic X-ray exposure in other industrialised countries for which data were available varied from 0.6 -1.8% and over 3% in Japan (the country with the highest estimated annual diagnostic X-ray use in the world). The UK's estimates were among the lowest because the annual frequency of diagnostic X-ray exposure was lower than in the other countries studied.

The authors conclude: 'Our calculations depended on a number of assumptions, and so are inevitably subject to considerable uncertainty. The possibility that we have overestimated the risks cannot be ruled out, but it seems unlikely that we have underestimated
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
29-Jan-2004


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: study quantifies cancer risk from diagnostic rays

(Date:6/18/2013)... Seven-year-old Riley Salz of Encino, California, is ... 40 hours a week of applied behavior analysis (ABA) ... for Autism and Related Disorders (CARD). Riley has been ... experienced remarkable progress, including learning to speak, starting conversations, ... journey through autism is now featured in CARD’s “Mission ...
(Date:6/18/2013)... at Case Western Reserve University,s College of Arts ... made available avatarsvirtual patientsto train speech-language pathologists. ... to evaluate speech-language disorders to practice using an ... because a diagnosis doesn,t have to be made ... studying to become speech-language pathologists have previously relied ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The Elizabeth ... of State and the U.S. President’s Emergency Plan for ... and celebrate significant new milestones in the global effort ... John Kerry announced that as of June 2013, one ... PEPFAR support. Since PEPFAR’s inception in 2003, EGPAF ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 A new ... storm. The burgeoning aquaculture industry is redefining the way ... of the most acclaimed personal culinary chefs on the ... on benefits of sustainable seafood and the promising industry ... abundance these days. Many consumers strive to fully partake ...
(Date:6/18/2013)... NY (PRWEB) June 18, 2013 New York ... Center to its “Best Doctors” list, up from 129 ... York City. The new issue also lists 52 additional doctors ... continues on a strategic growth trajectory. The “Best Doctors” issue, ... in the June 24 print issue and is available online ...
Breaking Medicine News(10 mins):Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3Health News:SimuCase avatars advance speech-language pathology training 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3
(Date:6/17/2013)... June 17, 2013 Vanda Pharmaceuticals Inc. ... data today at ENDO 2013, the Endocrine Society,s ... can entrain (synchronize) both melatonin and cortisol rhythms. ... the master body clock and address the circadian ... The SET (Safety and Efficacy of Tasimelteon) and ...
(Date:6/17/2013)... DNAtrix Inc., experts in oncolytic virus development, ... on the company,s lead product, DNX-2401, at the Replicating ... Canada on June 18, 2013. ... leader in the field of oncolytic virus therapy, will ... I TRIAL OF A CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS DNX-2401 (FORMERLY ...
(Date:6/17/2013)... , June 17, 2013 BioMed Realty Trust, Inc. ... of directors has declared a second quarter 2013 dividend of ... to an annualized dividend of $0.94 per common share. ... 15, 2013 to stockholders of record at the close of ... Realty Trust BioMed Realty delivers optimal real estate ...
Breaking Medicine Technology:Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3
Cached News: